# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-24-028152
Filing Date
2024-07-17
Accepted
2024-07-17 14:55:12
Documents
30
Period of Report
2024-07-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 45782
2 |  | ex3-19.htm | EX-3.19 | 7145
3 |  | ex3-20.htm | EX-3.20 | 4553
4 |  | ex99-1.htm | EX-99.1 | 14703
5 |  | ex3-19_001.jpg | GRAPHIC | 604173
6 |  | ex3-19_002.jpg | GRAPHIC | 596136
7 |  | ex3-19_003.jpg | GRAPHIC | 807721
8 |  | ex3-19_004.jpg | GRAPHIC | 682117
9 |  | ex3-19_005.jpg | GRAPHIC | 774217
10 |  | ex3-19_006.jpg | GRAPHIC | 756250
11 |  | ex3-19_007.jpg | GRAPHIC | 709353
12 |  | ex3-19_008.jpg | GRAPHIC | 731572
13 |  | ex3-19_009.jpg | GRAPHIC | 808918
14 |  | ex3-20_001.jpg | GRAPHIC | 604887
15 |  | ex3-20_002.jpg | GRAPHIC | 948197
16 |  | ex3-20_003.jpg | GRAPHIC | 793058
17 |  | ex3-20_004.jpg | GRAPHIC | 777522
18 |  | ex3-20_005.jpg | GRAPHIC | 816155
| Complete submission text file | 0001493152-24-028152.txt |  | 14591582

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
19 | XBRL SCHEMA FILE | alts-20240715.xsd | EX-101.SCH | 3009
20 | XBRL LABEL FILE | alts-20240715_lab.xml | EX-101.LAB | 34916
21 | XBRL PRESENTATION FILE | alts-20240715_pre.xml | EX-101.PRE | 22785
32 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3971

Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Filer) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19621 | Film No.: 241121899
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)